Cargando…
Isotretinoin Oil-Based Capsule Formulation Optimization
The purpose of this study was to develop and optimize an isotretinoin oil-based capsule with specific dissolution pattern. A three-factor-constrained mixture design was used to prepare the systemic model formulations. The independent factors were the components of oil-based capsule including beeswax...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771438/ https://www.ncbi.nlm.nih.gov/pubmed/24068886 http://dx.doi.org/10.1155/2013/856967 |
_version_ | 1782284199045103616 |
---|---|
author | Tsai, Pi-Ju Huang, Chi-Te Lee, Chen-Chou Li, Chi-Lin Huang, Yaw-Bin Tsai, Yi-Hung Wu, Pao-Chu |
author_facet | Tsai, Pi-Ju Huang, Chi-Te Lee, Chen-Chou Li, Chi-Lin Huang, Yaw-Bin Tsai, Yi-Hung Wu, Pao-Chu |
author_sort | Tsai, Pi-Ju |
collection | PubMed |
description | The purpose of this study was to develop and optimize an isotretinoin oil-based capsule with specific dissolution pattern. A three-factor-constrained mixture design was used to prepare the systemic model formulations. The independent factors were the components of oil-based capsule including beeswax (X (1)), hydrogenated coconut oil (X (2)), and soybean oil (X (3)). The drug release percentages at 10, 30, 60, and 90 min were selected as responses. The effect of formulation factors including that on responses was inspected by using response surface methodology (RSM). Multiple-response optimization was performed to search for the appropriate formulation with specific release pattern. It was found that the interaction effect of these formulation factors (X (1) X (2), X (1) X (3), and X (2) X (3)) showed more potential influence than that of the main factors (X (1), X (2), and X (3)). An optimal predicted formulation with Y (10 min), Y (30 min), Y (60 min), and Y (90 min) release values of 12.3%, 36.7%, 73.6%, and 92.7% at X (1), X (2), and X (3) of 5.75, 15.37, and 78.88, respectively, was developed. The new formulation was prepared and performed by the dissolution test. The similarity factor f (2) was 54.8, indicating that the dissolution pattern of the new optimized formulation showed equivalence to the predicted profile. |
format | Online Article Text |
id | pubmed-3771438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37714382013-09-25 Isotretinoin Oil-Based Capsule Formulation Optimization Tsai, Pi-Ju Huang, Chi-Te Lee, Chen-Chou Li, Chi-Lin Huang, Yaw-Bin Tsai, Yi-Hung Wu, Pao-Chu ScientificWorldJournal Research Article The purpose of this study was to develop and optimize an isotretinoin oil-based capsule with specific dissolution pattern. A three-factor-constrained mixture design was used to prepare the systemic model formulations. The independent factors were the components of oil-based capsule including beeswax (X (1)), hydrogenated coconut oil (X (2)), and soybean oil (X (3)). The drug release percentages at 10, 30, 60, and 90 min were selected as responses. The effect of formulation factors including that on responses was inspected by using response surface methodology (RSM). Multiple-response optimization was performed to search for the appropriate formulation with specific release pattern. It was found that the interaction effect of these formulation factors (X (1) X (2), X (1) X (3), and X (2) X (3)) showed more potential influence than that of the main factors (X (1), X (2), and X (3)). An optimal predicted formulation with Y (10 min), Y (30 min), Y (60 min), and Y (90 min) release values of 12.3%, 36.7%, 73.6%, and 92.7% at X (1), X (2), and X (3) of 5.75, 15.37, and 78.88, respectively, was developed. The new formulation was prepared and performed by the dissolution test. The similarity factor f (2) was 54.8, indicating that the dissolution pattern of the new optimized formulation showed equivalence to the predicted profile. Hindawi Publishing Corporation 2013-08-26 /pmc/articles/PMC3771438/ /pubmed/24068886 http://dx.doi.org/10.1155/2013/856967 Text en Copyright © 2013 Pi-Ju Tsai et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tsai, Pi-Ju Huang, Chi-Te Lee, Chen-Chou Li, Chi-Lin Huang, Yaw-Bin Tsai, Yi-Hung Wu, Pao-Chu Isotretinoin Oil-Based Capsule Formulation Optimization |
title | Isotretinoin Oil-Based Capsule Formulation Optimization |
title_full | Isotretinoin Oil-Based Capsule Formulation Optimization |
title_fullStr | Isotretinoin Oil-Based Capsule Formulation Optimization |
title_full_unstemmed | Isotretinoin Oil-Based Capsule Formulation Optimization |
title_short | Isotretinoin Oil-Based Capsule Formulation Optimization |
title_sort | isotretinoin oil-based capsule formulation optimization |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771438/ https://www.ncbi.nlm.nih.gov/pubmed/24068886 http://dx.doi.org/10.1155/2013/856967 |
work_keys_str_mv | AT tsaipiju isotretinoinoilbasedcapsuleformulationoptimization AT huangchite isotretinoinoilbasedcapsuleformulationoptimization AT leechenchou isotretinoinoilbasedcapsuleformulationoptimization AT lichilin isotretinoinoilbasedcapsuleformulationoptimization AT huangyawbin isotretinoinoilbasedcapsuleformulationoptimization AT tsaiyihung isotretinoinoilbasedcapsuleformulationoptimization AT wupaochu isotretinoinoilbasedcapsuleformulationoptimization |